Loading
A phase 2 trial in triple-negative breast cancer, run by Fudan University, now recruiting.
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors. is a phase 2, interventional study registered as NCT06889610 by Fudan University, with a registry enrolment figure of 95 participants, started 2026-03-30 and due to reach its primary completion in 2027-12-30. Interventions recorded: MTT(Multimodal Tumor Thermal Therapy System)- Colorectal Cancer; MTT(Multimodal Tumor Thermal Therapy System)- Triple-Negative Breast Cancer; MTT(Multimodal Tumor Thermal Therapy System)- Melanoma. Conditions listed: Triple Negative Breast Cancer Metastatic; Melanoma Metastatic; Colorectal Cancer Metastatic. Triple-negative eligibility wording from the registry: "Triple-negative breast cancer :". Sites: China. No results are recorded here; the registry entry is the source.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.